V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20205731 | 20167442 | 1.63 | 62.6 | Palliative (P) | 2018-03-01 | 2018-04-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101105430 |
| 20205761 | 20167443 | 1.86 | 80 | Curative (C) | 2016-07-17 | 2016-09-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100798774 |
| 20205779 | 20167444 | 1.7 | 85 | Palliative (P) | 2020-12-30 | 2020-12-31 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100228095 |
| 20205793 | 20167445 | 1.67 | 53.6 | Adjuvant (A) | 2021-02-15 | 2021-02-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101673017 |
| 20205803 | 20167447 | 1.82 | 47.6 | Palliative (P) | 2019-11-06 | 2019-11-14 | Docetaxel | 02 | N | DOCETAXEL | 101421158 |
| 20205810 | 20167448 | 1.81 | 89.6 | Palliative (P) | 2019-07-08 | 2020-07-02 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100854273 |
| 20205831 | 20167449 | 1.76 | 46.7 | Palliative (P) | 2019-12-06 | 2019-12-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101066642 |
| 20205840 | 20167450 | 1.55 | 79 | null | 2020-09-13 | 2020-09-24 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100709943 |
| 20205868 | 20167451 | 1.78 | 72 | Palliative (P) | 2017-11-24 | 2017-12-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101457085 |
| 20205913 | 20167452 | 1.61 | 65 | Palliative (P) | 2017-03-26 | 2017-03-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100918961 |
| 20205917 | 20167453 | 1.81 | 74 | Adjuvant (A) | 2018-08-27 | 2018-09-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 100269143 |
| 20205918 | 20167454 | 1.68 | 81.4 | Adjuvant (A) | 2019-07-22 | 2019-08-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101708025 |
| 20205925 | 20167455 | 1.9 | 63.9 | null | 2020-11-01 | 2020-12-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101796788 |
| 20205926 | 20167456 | 1.63 | 50.4 | Palliative (P) | 2021-03-14 | 2021-04-23 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100544955 |
| 20205941 | 20167457 | 1.74 | 98 | Palliative (P) | 2019-01-19 | 2019-07-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100291863 |
| 20205947 | 20167458 | 1.74 | 76 | Palliative (P) | 2019-05-03 | 2019-05-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100507003 |
| 20205961 | 20167459 | 1.66 | 101 | Palliative (P) | 2017-03-24 | 2017-03-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101016773 |
| 20205962 | 20167460 | 1.63 | 49.1 | null | 2022-01-16 | 2022-01-23 | CETUXIMAB + IRINOTECAN + MDG | 01 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101806784 |
| 20205964 | 20167461 | 1.55 | 63 | null | 2018-02-12 | 2018-03-07 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100377174 |
| 20205987 | 20167462 | 1.56 | 56.8 | null | 2017-09-30 | 2017-11-11 | Docetaxel | 02 | null | DOCETAXEL | 101196084 |
| 20205989 | 20167463 | 1.68 | 74.8 | Palliative (P) | 2019-03-30 | 2019-03-31 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100506754 |
| 20206004 | 20167464 | 1.7 | 57.4 | Palliative (P) | 2018-05-17 | 2018-05-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101120290 |
| 20206009 | 20167465 | 1.64 | 73.5 | Palliative (P) | 2017-03-21 | 2017-03-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101457426 |
| 20206012 | 20167466 | 1.66 | 69.1 | null | 2020-12-12 | 2020-12-25 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100419501 |
| 20206016 | 20167467 | 1.67 | 58 | Palliative (P) | 2019-03-05 | 2019-03-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101280372 |
| 20206017 | 20167468 | 1.69 | 65.6 | null | 2018-03-28 | 2018-08-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100884593 |
| 20206018 | 20167469 | 1.63 | 61.8 | Palliative (P) | 2019-06-25 | 2019-07-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | CAPECITABINE + GEMCITABINE | 100396195 |
| 20206033 | 20167470 | 1.61 | 89.3 | null | 2018-01-07 | 2018-01-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100784357 |
| 20206061 | 20167471 | 1.74 | 79 | Palliative (P) | 2018-11-07 | 2018-11-19 | Docetaxel | 02 | N | DOCETAXEL | 101793675 |
| 20206068 | 20167472 | 1.81 | 85.3 | Palliative (P) | 2020-12-28 | 2021-01-05 | Docetaxel | 02 | N | DOCETAXEL | 100953390 |
| 20206098 | 20167473 | 1.7 | 71 | null | 2016-08-05 | 2017-01-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101857487 |
| 20206128 | 20167474 | 1.84 | 74.15 | Palliative (P) | 2018-03-15 | 2022-02-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101682190 |
| 20206140 | 20167475 | 1.84 | 61.9 | null | 2017-05-16 | 2017-05-26 | Docetaxel | 02 | null | DOCETAXEL | 100642801 |
| 20206142 | 20167476 | 1.85 | 80.6 | Curative (C) | 2015-05-12 | 2016-05-01 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100413522 |
| 20206143 | 20167477 | 1.84 | 108 | Curative (C) | 2016-08-01 | 2017-08-14 | Trastuzumab | 02 | N | TRASTUZUMAB | 100822206 |
| 20206144 | 20167478 | 1.77 | 54.4 | null | 2017-02-20 | 2017-03-07 | Capecitabine + Cisplatin + RT | null | null | CAPECITABINE + CISPLATIN | 100461360 |
| 20206156 | 20167479 | 1.76 | 92 | Palliative (P) | 2018-10-29 | 2018-11-23 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101252308 |
| 20206166 | 20167480 | 1.83 | 75 | Curative (C) | 2019-01-11 | 2019-01-24 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101045483 |
| 20206181 | 20167481 | 1.96 | 57 | Curative (C) | null | 2019-10-12 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101584683 |
| 20206202 | 20167482 | 1.52 | 52.4 | Neo-adjuvant (N) | 2017-04-24 | 2017-05-17 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100081056 |
| 20206209 | 20167483 | 1.66 | 0 | null | 2020-07-13 | 2020-07-16 | CETUXIMAB | 02 | null | CETUXIMAB | 100281249 |
| 20206228 | 20167485 | 1.78 | 73.4 | null | 2021-05-06 | 2021-05-21 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100872432 |
| 20206245 | 20167486 | 1.63 | 60.1 | Palliative (P) | 2021-02-08 | 2021-03-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 100747155 |
| 20206249 | 20167487 | 1.72 | 105 | Palliative (P) | null | 2019-12-11 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101843169 |
| 20206278 | 20167488 | 1.66 | 76.7 | Curative (C) | 2017-07-14 | 2018-09-27 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101751888 |
| 20206288 | 20167489 | 1.75 | 88.4 | Palliative (P) | 2020-01-19 | 2020-02-10 | Cetuximab 7 day (>Cycle 2) | 02 | N | CETUXIMAB | 100370774 |
| 20206291 | 20167490 | 1.73 | 74.4 | Neo-adjuvant (N) | 2018-08-28 | 2018-08-28 | Trastuzumab 21 day loading dose | N | N | TRASTUZUMAB | 100878353 |
| 20206308 | 20167491 | 0 | 44.6 | Palliative (P) | 2020-10-08 | 2020-10-25 | Cetuximab 14 day | null | N | CAPECITABINE + CISPLATIN | 100676687 |
| 20206315 | 20167492 | 1.83 | 62.2 | Curative (C) | null | 2017-02-10 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100830256 |
| 20206319 | 20167493 | 1.7 | 56.7 | Neo-adjuvant (N) | 2020-08-07 | 2020-08-07 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101310959 |